Education
About Us
Working with TipRanks
Follow Us
Diagnos (TSE:ADK)
:ADK
Total Valuation
Diagnos has a market cap or net worth of C$19.35M. The enterprise value is C$25.13M.
Market CapC$19.35M
Enterprise ValueC$25.13M
Share Statistics
Diagnos has 101,862,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding101,862,976
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Diagnos’s return on equity (ROE) is 1.02 and return on invested capital (ROIC) is -2007.95%.
Return on Equity (ROE)1.02
Return on Assets (ROA)-4.70
Return on Invested Capital (ROIC)-2007.95%
Return on Capital Employed (ROCE)2.80
Revenue Per Employee10.63K
Profits Per Employee-195.04K
Employee Count16
Asset Turnover0.26
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Diagnos is -6.42. Diagnos’s PEG ratio is -0.36.
PE Ratio-6.42
PS Ratio0.00
PB Ratio-214.66
Price to Fair Value-6.56
Price to FCF-11.78
Price to Operating Cash Flow-11.96
PEG Ratio-0.36
Income Statement
In the last 12 months, Diagnos had revenue of 170.16K and earned -3.12M in profits. Earnings per share was -0.04.
Revenue170.16K
Gross Profit35.80K
Operating Income-2.69M
Pretax Income-3.12M
Net Income-3.12M
EBITDA-2.45M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -2.99M and capital expenditures -13.21K, giving a free cash flow of -3.00M billion.
Operating Cash Flow-2.99M
Free Cash Flow-3.00M
Free Cash Flow per Share-0.03
Dividends & Yields
Diagnos pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.16
52-Week Price Change-33.33%
50-Day Moving Average0.22
200-Day Moving Average0.30
Relative Strength Index (RSI)45.48
Average Volume (3m)125.44K
Important Dates
Diagnos upcoming earnings date is Aug 21, 2025, TBA (Confirmed).
Last Earnings DateMay 28, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend Date―
Financial Position
Diagnos as a current ratio of 0.25, with Debt / Equity ratio of -1044.65%
Current Ratio0.25
Quick Ratio0.25
Debt to Market Cap0.15
Net Debt to EBITDA-1.21
Interest Coverage Ratio-4.88
Taxes
In the past 12 months, Diagnos has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Diagnos EV to EBITDA ratio is -9.40, with an EV/FCF ratio of -10.65.
EV to Sales135.12
EV to EBITDA-9.40
EV to Free Cash Flow-10.65
EV to Operating Cash Flow-10.71
Balance Sheet
Diagnos has C$2.82M in cash and marketable securities with C$3.29M in debt, giving a net cash position of C$465.74K billion.
Cash & Marketable SecuritiesC$2.82M
Total DebtC$3.29M
Net CashC$465.74K
Net Cash Per Share<C$0.01
Tangible Book Value Per Share-C$0.04
Margins
Gross margin is -95.32%, with operating margin of -1578.00%, and net profit margin of -1833.93%.
Gross Margin-95.32%
Operating Margin-1578.00%
Pretax Margin-1833.93%
Net Profit Margin-1833.93%
EBITDA Margin-1437.61%
EBIT Margin-1510.60%
Analyst Forecast
The average price target for Diagnos is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-35.15%
EPS Growth Forecast-6.59%